247 related articles for article (PubMed ID: 31137733)
1. Identification of Crucial Candidate Genes and Pathways in Glioblastoma Multiform by Bioinformatics Analysis.
Alshabi AM; Vastrad B; Shaikh IA; Vastrad C
Biomolecules; 2019 May; 9(5):. PubMed ID: 31137733
[TBL] [Abstract][Full Text] [Related]
2. Gene regulation network analysis reveals core genes associated with survival in glioblastoma multiforme.
Jiang L; Zhong M; Chen T; Zhu X; Yang H; Lv K
J Cell Mol Med; 2020 Sep; 24(17):10075-10087. PubMed ID: 32696617
[TBL] [Abstract][Full Text] [Related]
3. Identify signature regulatory network for glioblastoma prognosis by integrative mRNA and miRNA co-expression analysis.
Bing ZT; Yang GH; Xiong J; Guo L; Yang L
IET Syst Biol; 2016 Dec; 10(6):244-251. PubMed ID: 27879479
[TBL] [Abstract][Full Text] [Related]
4. Identification of candidate biomarkers for GBM based on WGCNA.
Sun Q; Wang Z; Xiu H; He N; Liu M; Yin L
Sci Rep; 2024 May; 14(1):10692. PubMed ID: 38724609
[TBL] [Abstract][Full Text] [Related]
5. mRNA markers for survival prediction in glioblastoma multiforme patients: a systematic review with bioinformatic analyses.
Azimi P; Yazdanian T; Ahmadiani A
BMC Cancer; 2024 May; 24(1):612. PubMed ID: 38773447
[TBL] [Abstract][Full Text] [Related]
6. Transcriptomics and network analysis highlight potential pathways in the pathogenesis of pterygium.
de Guimarães JA; Hounpke BW; Duarte B; Boso ALM; Viturino MGM; de Carvalho Baptista L; de Melo MB; Alves M
Sci Rep; 2022 Jan; 12(1):286. PubMed ID: 34997134
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel glioblastoma multiforme molecular subtype with poor prognosis and high immune infiltration based on oxidative stress-related genes.
Huang G; Hou X; Li X; Yu Y; Ge X; Gan H
Medicine (Baltimore); 2024 Feb; 103(7):e35828. PubMed ID: 38363895
[TBL] [Abstract][Full Text] [Related]
8. Potential Drug Prediction of Glioblastoma Based on Drug Perturbation-Induced Gene Expression Signatures.
Zhu B; Mao X; Man Y
Biomed Res Int; 2021; 2021():6659701. PubMed ID: 33575336
[TBL] [Abstract][Full Text] [Related]
9. The potential crosstalk genes and molecular mechanisms between glioblastoma and periodontitis.
Huang JH; Chen Y; Kang YB; Yao ZJ; Song JH
Sci Rep; 2024 Mar; 14(1):5970. PubMed ID: 38472293
[TBL] [Abstract][Full Text] [Related]
10. Integrated regulatory models for inference of subtype-specific susceptibilities in glioblastoma.
Liu Y; Shi N; Regev A; He S; Hemann MT
Mol Syst Biol; 2020 Sep; 16(9):e9506. PubMed ID: 32974985
[TBL] [Abstract][Full Text] [Related]
11. Surprisal analysis of Glioblastoma Multiform (GBM) microRNA dynamics unveils tumor specific phenotype.
Zadran S; Remacle F; Levine R
PLoS One; 2014; 9(9):e108171. PubMed ID: 25265448
[TBL] [Abstract][Full Text] [Related]
12. Small molecule drug discovery for glioblastoma treatment based on bioinformatics and cheminformatics approaches.
Feng L; Zhu S; Ma J; Huang J; Hou X; Qiu Q; Zhang T; Wan M; Li J
Front Pharmacol; 2024; 15():1389440. PubMed ID: 38681202
[No Abstract] [Full Text] [Related]
13. A human functional protein interaction network and its application to cancer data analysis.
Wu G; Feng X; Stein L
Genome Biol; 2010; 11(5):R53. PubMed ID: 20482850
[TBL] [Abstract][Full Text] [Related]
14. Identification of key genes in sepsis-induced cardiomyopathy based on integrated bioinformatical analysis and experiments
Liu D; Wang T; Wang Q; Dong P; Liu X; Li Q; Shi Y; Li J; Zhou J; Zhang Q
PeerJ; 2023; 11():e16222. PubMed ID: 38025678
[TBL] [Abstract][Full Text] [Related]
15. Integrative Bioinformatics Analysis of The Cell Division Cycle and Ribosomal Pathways in The Rat Varicocele: Implications for Drug Discovery.
Nasr-Esfahani A; Valipour Motlagh A; Adib M; Pashaei K; Nasr-Esfahani MH
Cell J; 2023 Oct; 25(10):727-737. PubMed ID: 37865881
[TBL] [Abstract][Full Text] [Related]
16. System biology approach to identify the novel biomarkers in glioblastoma multiforme tumors by using computational analysis.
Alqahtani SM; Altharawi A; Alabbas A; Ahmad F; Ayaz H; Nawaz A; Rahman S; Alossaimi MA
Front Pharmacol; 2024; 15():1364138. PubMed ID: 38841373
[No Abstract] [Full Text] [Related]
17. Pharmacogenomic Analysis of Combined Therapies against Glioblastoma Based on Cell Markers from Single-Cell Sequencing.
Liu J; Wu R; Yuan S; Kelleher R; Chen S; Chen R; Zhang T; Obaidi I; Sheridan H
Pharmaceuticals (Basel); 2023 Oct; 16(11):. PubMed ID: 38004399
[TBL] [Abstract][Full Text] [Related]
18. Exploration of functional relations among differentially co-expressed genes identifies regulators in glioblastoma.
Kumar S; Sarmah DT; Paul A; Chatterjee S
Comput Biol Chem; 2024 Apr; 109():108024. PubMed ID: 38335855
[TBL] [Abstract][Full Text] [Related]
19. Integrative analysis of somatic mutations and differential expression profiles in glioblastoma based on aging acceleration.
Wang H; Li S; Liu H; Bian S; Huang W; Xing C; Wang Y
Int J Clin Exp Pathol; 2021; 14(5):582-595. PubMed ID: 34093944
[TBL] [Abstract][Full Text] [Related]
20. Explorative Discovery of Gene Signatures and Clinotypes in Glioblastoma Cancer Through GeneTerrain Knowledge Map Representation.
Saghapour E; Yue Z; Sharma R; Kumar S; Sembay Z; Willey CD; Chen JY
bioRxiv; 2024 Apr; ():. PubMed ID: 38617348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
